Related Experiment Video
Updated: Jul 10, 2026
07:42
Advanced Abdominal Aortic Aneurysm Modeling in Mice by Combination of Topical Elastase and Oral ß-aminopropionitrile
Published on: July 26, 2024
ENDOCOM : abdominal aortic aneurysm test bench for in vitro simulation.
Johan Mazeyrat1, Olivier Romain, Patrick Garda
1Université Pierre et Marie Curie, SYEL équipe d'acceuil 2385, Service de Chirurgie Thoracique et Cardio-Vasculaire, Paris, France.
Summary
This study introduces a novel communicative stent with an integrated pressure sensor to monitor abdominal aortic aneurysm (AAA) treatment. This innovation aims to improve post-operative follow-up and reduce complications associated with endovascular AAA repair.
Area of Science:
- Biomedical Engineering
- Cardiovascular Surgery
- Medical Device Innovation
Background:
- Abdominal aortic aneurysm (AAA) rupture is a life-threatening complication.
- Endovascular stent grafts are used for AAA treatment but have a ~25% failure rate due to persistent sac pressure.
- Current follow-up methods like CT scans and MRIs are not always reliable.
Purpose of the Study:
- To design and develop a communicative stent with an integrated pressure sensor for AAA post-operative monitoring.
- To create a numerical model for simulating aortic blood flow and pressure dynamics.
- To establish an experimental testbench for validating the sensor's measurement principle.
Main Methods:
- Conception and design of a communicative stent with an integrated pressure sensor.
- Elaboration of a numerical model to simulate aortic flux across an AAA.
- Development of an experimental testbench to replicate aortic flow conditions.
Main Results:
- The paper details the design of the communicative sensor.
- A numerical model for AAA hemodynamic simulation was developed.
- An experimental setup was created for sensor validation under simulated aortic conditions.
Conclusions:
- The developed communicative stent offers a potential solution for improved AAA post-operative monitoring.
- The integrated pressure sensor aims to provide real-time data, enhancing treatment efficacy.
- Further validation and clinical studies are needed to confirm the device's utility in managing AAA.
